168 related articles for article (PubMed ID: 24323514)
1. Opportunistic diseases in HIV-infected patients in Gabon following the administration of highly active antiretroviral therapy: a retrospective study.
Okome-Nkoumou M; Guiyedi V; Ondounda M; Efire N; Clevenbergh P; Dibo M; Dzeing-Ella A
Am J Trop Med Hyg; 2014 Feb; 90(2):211-5. PubMed ID: 24323514
[TBL] [Abstract][Full Text] [Related]
2. Incidence and predictors of HIV related opportunistic infections after initiation of highly active antiretroviral therapy at Ayder Referral Hospital, Mekelle, Ethiopia: A retrospective single centered cohort study.
Arefaine ZG; Abebe S; Bekele E; Adem A; Adama Y; H Brockmeyer N; Coenenberg J; Potthoff A; Gebremeskel TG
PLoS One; 2020; 15(4):e0229757. PubMed ID: 32310961
[TBL] [Abstract][Full Text] [Related]
3. Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy.
Dankner WM; Lindsey JC; Levin MJ;
Pediatr Infect Dis J; 2001 Jan; 20(1):40-8. PubMed ID: 11176565
[TBL] [Abstract][Full Text] [Related]
4. Update on opportunistic infections in the era of effective antiretroviral therapy.
Zanoni BC; Gandhi RT
Infect Dis Clin North Am; 2014 Sep; 28(3):501-18. PubMed ID: 25151568
[TBL] [Abstract][Full Text] [Related]
5. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
6. Treatment of opportunistic infections prior to HAART initiation does not affect immune reconstitution in HIV-infected patients.
Pornprasert S; Traisathit P; Singboottra P; Huong NN
Curr HIV Res; 2012 Oct; 10(7):592-6. PubMed ID: 22973852
[TBL] [Abstract][Full Text] [Related]
7. Natural history of opportunistic disease in an HIV-infected urban clinical cohort.
Moore RD; Chaisson RE
Ann Intern Med; 1996 Apr; 124(7):633-42. PubMed ID: 8607591
[TBL] [Abstract][Full Text] [Related]
8. Frequency and distribution patterns of opportunistic infections associated with HIV/AIDS in Uganda.
Rubaihayo J; Tumwesigye NM; Konde-Lule J; Wamani H; Nakku-Joloba E; Makumbi F
BMC Res Notes; 2016 Dec; 9(1):501. PubMed ID: 27927247
[TBL] [Abstract][Full Text] [Related]
9. Incidence of opportunistic and other infections in HIV-infected children in the HAART era.
Gona P; Van Dyke RB; Williams PL; Dankner WM; Chernoff MC; Nachman SA; Seage GR
JAMA; 2006 Jul; 296(3):292-300. PubMed ID: 16849662
[TBL] [Abstract][Full Text] [Related]
10. Types and prevalence of HIV-related opportunistic infections/conditions among HIV-positive patients attending Kenyatta National Hospital in Nairobi, Kenya.
Chepkondol GK; Jolly PE; Yatich N; Mbowe O; Jaoko WG
Afr Health Sci; 2020 Jun; 20(2):615-624. PubMed ID: 33163022
[TBL] [Abstract][Full Text] [Related]
11. Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006.
Wood SM; Shah SS; Steenhoff AP; Rutstein RM
Pediatrics; 2008 Jan; 121(1):e150-6. PubMed ID: 18086820
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of T-cell subsets and their relationship with oral and systemic opportunistic infections in HIV/AIDS patients during the first year of HAART in Guangxi, China.
Zhang L; Huang Y; Liu Z; Liu W; Qin Q; Tao R
J Med Virol; 2015 Jul; 87(7):1158-67. PubMed ID: 25777553
[TBL] [Abstract][Full Text] [Related]
13. Oral candidiasis in human immunodeficiency virus-infected patients under highly active antiretroviral therapy.
Shekatkar M; Kheur S; Gupta AA; Arora A; Raj AT; Patil S; Khan SS; Desai A; Carroll WB; Awan KH
Dis Mon; 2021 Sep; 67(9):101169. PubMed ID: 33640178
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of oral candidiasis in HIV/AIDS children in highly active antiretroviral therapy era. A literature analysis.
Gaitán-Cepeda LA; Sánchez-Vargas O; Castillo N
Int J STD AIDS; 2015 Aug; 26(9):625-32. PubMed ID: 25156369
[TBL] [Abstract][Full Text] [Related]
15. [Opportunistic episodes in patients infected with the human immunodeficiency virus during the first 6 months of HAART].
González-Castillo J; Blanco F; Soriano V; Barreiro P; Concepción Bravo M; Jiménez-Nácher I; González-Lahoz J
Med Clin (Barc); 2001 Jun; 117(3):81-4. PubMed ID: 11459574
[TBL] [Abstract][Full Text] [Related]
16. Predictors of opportunistic illnesses incidence in post combination antiretroviral therapy era in an urban cohort from Rio de Janeiro, Brazil.
Coelho LE; Cardoso SW; Amancio RT; Moreira RI; Ribeiro SR; Coelho AB; Campos DP; Veloso VG; Grinsztejn B; Luz PM
BMC Infect Dis; 2016 Mar; 16():134. PubMed ID: 27001753
[TBL] [Abstract][Full Text] [Related]
17. The sound of one hand clapping: tuberculosis and antiretroviral therapy in Africa.
De Cock KM; Marston B
Am J Respir Crit Care Med; 2005 Jul; 172(1):3-4. PubMed ID: 15980107
[No Abstract] [Full Text] [Related]
18. HIV and tuberculosis--a "cursed duo" in the HAART era.
Londhey VA
J Assoc Physicians India; 2009 Oct; 57():681-2. PubMed ID: 20329423
[No Abstract] [Full Text] [Related]
19. Incidence of opportunistic illness before and after initiation of highly active antiretroviral therapy in children.
Nesheim SR; Hardnett F; Wheeling JT; Siberry GK; Paul ME; Emmanuel P; Bohannon B; Dominguez K;
Pediatr Infect Dis J; 2013 Oct; 32(10):1089-95. PubMed ID: 24067552
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with mortality among HIV-infected patients in the era of highly active antiretroviral therapy in southern India.
Kumarasamy N; Venkatesh KK; Devaleenol B; Poongulali S; Yephthomi T; Pradeep A; Saghayam S; Flanigan T; Mayer KH; Solomon S
Int J Infect Dis; 2010 Feb; 14(2):e127-31. PubMed ID: 19632872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
